Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, Berlin 14195, Germany.
FG13 Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Burgstraße 37, Wernigerode 38855, Germany.
J Med Chem. 2023 Sep 14;66(17):11761-11791. doi: 10.1021/acs.jmedchem.3c00171. Epub 2023 Aug 16.
Carbapenem resistance mediated by metallo-β-lactamases (MBL) such as New Delhi metallo-β-lactamase-1 (NDM-1) has become a major factor threatening the efficacy of essential β-lactam antibiotics. Starting from hit fragment dipicolinic acid (DPA), 8-hydroxy- and 8-sulfonamido-quinoline-2-carboxylic acids were developed as inhibitors of NDM-1 with highly improved inhibitory activity and binding affinity. The most active compounds formed reversibly inactive ternary protein-inhibitor complexes with two zinc ions as proven by native protein mass spectrometry and bio-layer interferometry. Modification of the NDM-1 structure with remarkable entropic gain was shown by isothermal titration calorimetry and NMR spectroscopy of isotopically labeled protein. The best compounds were potent inhibitors of NDM-1 and other representative MBL with no or little inhibition of human zinc-binding enzymes. These inhibitors significantly reduced the minimum inhibitory concentrations (MIC) of meropenem for multidrug-resistant bacteria recombinantly expressing as well as for several multidrug-resistant clinical strains at concentrations non-toxic to human cells.
金属β-内酰胺酶(MBL)介导的碳青霉烯类耐药,如新德里金属β-内酰胺酶-1(NDM-1),已成为威胁重要β-内酰胺类抗生素疗效的主要因素。以起始命中片段二吡啶甲酸(DPA)为基础,8-羟基-和 8-磺酰胺基喹啉-2-羧酸被开发为 NDM-1 的抑制剂,具有高度改善的抑制活性和结合亲和力。通过天然蛋白质质谱和生物层干涉测量证明,最活跃的化合物与两个锌离子形成可逆失活的三元蛋白-抑制剂复合物。通过对标记有同位素的蛋白质进行等温滴定量热法和 NMR 光谱分析,显示了 NDM-1 结构的显著熵增益修饰。最佳化合物是 NDM-1 和其他代表性 MBL 的有效抑制剂,对人类锌结合酶几乎没有或没有抑制作用。这些抑制剂显著降低了重组表达 以及对几种多药耐药临床株的最低抑菌浓度(MIC),其浓度对人类细胞无毒。